Research & Development
-
Novavax's COVID-flu combo vaccine shows strong immune response in trial
-
Lilly’s Weight Loss Blockbuster cuts Heart Failure risk by 38%, halves Hospitalizations
-
Merck's cholesterol drug meets main goal in two studies
-
Otsuka's kidney disease drug shows over 50% reduction in protein in urine
-
ISB 2001 Shows High Response Rates in Phase 1 Myeloma Trial
-
Novartis' Pluvicto shown to slow prostate cancer in earlier setting
-
Gilead's Trodelvy, with Keytruda, cuts breast cancer risk by 35% in trial
-
Amgen blood platelet booster helps patients who need chemotherapy
Join the community of thousands of industry professionals
Subscribe to our Daily Newsletter
Follow us on Linkedin for latest industry updates
Get latest news, insider access to events, awards, webinars, and more
Advertisement